Alta Partners Management VIII, LLC's Net Worth

$28.1 Million

Estimate Recalculated Jul 10, 2024 03:14PM EST

Who is Alta Partners Management VIII, LLC?

Alta Partners Management VIII, LLC has an estimated net worth of $28.1 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., ANESIVA, INC., ZS Pharma, Inc., Allakos Inc., SUTRO BIOPHARMA INC, Esperion Therapeutics, Inc., TREVENA INC, APPLIED GENETIC TECHNOLOGIES CORP, aTYR PHARMA INC, Neothetics, Inc., and ATS MEDICAL INC.

SEC CIK

Alta Partners Management VIII, LLC's CIK is 0001399894

Past Insider Trading and Trends

2014 was Alta Partners Management VIII, LLC's most active year for acquiring shares with 26 total transactions. Alta Partners Management VIII, LLC's most active month to acquire stocks was the month of June. 2014 was Alta Partners Management VIII, LLC's most active year for disposing of shares, totalling 25 transactions. Alta Partners Management VIII, LLC's most active month to dispose stocks was the month of October. 2014 saw Alta Partners Management VIII, LLC paying a total of $28,496,905.70 for 16,799,389 shares, this is the most they've acquired in one year. In 2015 Alta Partners Management VIII, LLC cashed out on 16,213,092 shares for a total of $35,700,680.80, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNE DESIGN CORP. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.48M
$12.00
—
2.48M
Jul 29
Form 3
—
0
—
—
0
No matching records found

ANESIVA, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-6.04%
-404.65K
$0.09
-$37,146.87
6.29M
Jan 6
Form 3
—
0
—
—
0
No matching records found

ZS Pharma, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-6.22%
-175.43K
$57.86
-$10,149,794.76
2.65M
Jun 5 - Jun 8
Form 4
-3.80%
-111.60K
$57.30
-$6,394,775.58
2.82M
Jun 3 - Jun 4
Form 4
-9.18%
-296.42K
$58.00
-$17,192,294.53
2.93M
May 29 - Jun 2
Form 4
∞
3.23M
$18.00
—
3.23M
Jun 23
Form 3
—
0
—
—
0
No matching records found

Allakos Inc. (ALLK) Snapshot price: $1.26

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.45M
—
—
0
Aug 16
Form 4
-19.01%
-2.00M
—
—
8.52M
Jan 4
Form 4
-8.32%
-958.55K
—
—
10.56M
Jan 22
Form 4
∞
11.52M
$18.00
—
11.52M
Jul 23
Form 3
—
0
—
—
0
No matching records found

SUTRO BIOPHARMA INC (STRO) Snapshot price: $4.695

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.94M
—
—
1.94M
Oct 1
Form 3
—
0
—
—
0
No matching records found